glp 1 and gut microbiome Correlation between intestinal flora GLP-1 receptor agonist dulaglutide in type 2 diabetes mellitus treatment—A preliminary longitudinal study Metabolic and gut microbiome changes
Description
Hospitalization or urgent visit for heart failure was also decreased in the semaglutide group (2.3% vs 5.9%)
Avoiding it may be preferable
Nat Med 2023;29:150010.ArticlePubMedPDF 38
doi: 10.1146/annurev.med.52.1.319 20
The intriguing possibility that these agents might influence cancer progression has prompted researchers to explore their effects beyond diabetes management
